- In May 2024, Thermo Fisher Scientific introduced the Applied Biosystems TaqMan MiniChip PCR System, a compact and portable platform designed specifically for point-of-care settings. This innovation aims to meet the increasing demand for portable PCR solutions that enable rapid diagnostics in resource-limited environments. This launch contributes to the global PCR devices market as it reflects the growing trend towards miniaturized, easy-to-use diagnostic solutions
- In November 2023, F. Hoffmann-La Roche Ltd launched the LightCycler PRO System, a next-generation qPCR platform designed to address the evolving needs of molecular diagnostics in clinical settings. This development contributes to the global PCR devices market, as it demonstrates the continued innovation in qPCR technology aimed at improving diagnostic accuracy and efficiency
- In October 2023, Abbott Laboratories received clearance for its Alinity mPCR System, a real-time PCR platform designed for clinical laboratories. This automated and user-friendly system is intended to broaden access to PCR technology across various diagnostic applications. This development is significant for the global PCR devices market, as it underscores the growing demand for efficient, accessible, and scalable PCR solutions in clinical diagnostics
- In July 2021, PathStore announced the launch of its COVID-19 RT-PCR test in India at a competitive price, positioning it as one of the most affordable options available in the market. This rapid diagnostic test is designed to maximize the efficiency of COVID-19 detection, ensuring timely treatment for patients. This development is particularly contributed to the global PCR devices market, as it highlights the growing demand for cost-effective and accessible diagnostic solutions, especially in response to global health crises such as the COVID-19 pandemic
- In July 2021, PathStore launched its COVID-19 RT-PCR test in India at a highly competitive price, offering one of the most affordable options available in the market. This test is designed to optimize COVID-19 diagnostics, enabling timely and effective treatment for patients. This announcement highlights the growing demand for cost-effective and accessible diagnostic solutions, especially in regions with budgetary constraints
